The multiple facets of opioid receptor function: Implications for addiction

Current Opinion in Neurobiology

Volumn 23, Issue 4, 2013, Pages 473-479

  Lutz, Pierre Eric ^a   Kieffer, Brigitte L ^b  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; DELTA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; OPIATE RECEPTOR;

ADDICTION; ANXIETY; AVERSIVE BEHAVIOR; BEHAVIOR CONTROL; BRAIN FUNCTION; COGNITIVE DEFECT; COMORBIDITY; DECISION MAKING; DEPRESSION; DRUG SEEKING BEHAVIOR; EMOTIONALITY; HUMAN; IMPULSIVENESS; MENTAL STRESS; NEUROMODULATION; NEUROPATHOLOGY; NEUROPSYCHOLOGY; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW;

EID: 84881022559     PISSN: 09594388     EISSN: 18736882     Source Type: Journal    
DOI: 10.1016/j.conb.2013.02.005     Document Type: Review

References (63)

1. Koob G.F., Volkow N.D. Neurocircuitry of addiction. Neuropsychopharmacology 2010, 35:217-238.
2. Contet C., Kieffer B.L., Befort K. Mu opioid receptor: a gateway to drug addiction. Curr Opin Neurobiol 2004, 14:370-378.
3. Le Merrer J., Becker J.A., Befort K., Kieffer B.L. Reward processing by the opioid system in the brain. Physiol Rev 2009, 89:1379-1412.
4. Trezza V., Baarendse P.J., Vanderschuren L.J. The pleasures of play: pharmacological insights into social reward mechanisms. Trends Pharmacol Sci 2010, 31:463-469.
5. Meyer-Lindenberg A., Tost H. Neural mechanisms of social risk for psychiatric disorders. Nat Neurosci 2012, 15:663-668.
6. Way B.M., Taylor S.E., Eisenberger N.I. Variation in the mu-opioid receptor gene (OPRM1) is associated with dispositional and neural sensitivity to social rejection. Proc Natl Acad Sci U S A 2009, 106:15079-15084.
7. Troisi A., Frazzetto G., Carola V., Di Lorenzo G., Coviello M., D'Amato F.R., Moles A., Siracusano A., Gross C. Social hedonic capacity is associated with the A118G polymorphism of the mu-opioid receptor gene (OPRM1) in adult healthy volunteers and psychiatric patients. Soc Neurosci 2011, 6:88-97.
8. Mague S.D., Blendy J.A. OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models. Drug Alcohol Depend 2010, 108:172-182.
9. Oertel B.G., Doehring A., Roskam B., Kettner M., Hackmann N., Ferreiros N., Schmidt P.H., Lotsch J. Genetic-epigenetic interaction modulates mu-opioid receptor regulation. Hum Mol Genet 2012, 21:4751-4760.
10. Cinque C., Pondiki S., Oddi D., Di Certo M.G., Marinelli S., Troisi A., Moles A., D'Amato F.R. Modeling socially anhedonic syndromes: genetic and pharmacological manipulation of opioid neurotransmission in mice. Transl Psychiatry 2012, 2:e155.
11. Burkett J.P., Spiegel L.L., Inoue K., Murphy A.Z., Young L.J. Activation of mu-opioid receptors in the dorsal striatum is necessary for adult social attachment in monogamous prairie voles. Neuropsychopharmacology 2011, 36:2200-2210.
12. Volkow N.D., Baler R.D., Goldstein R.Z. Addiction: pulling at the neural threads of social behaviors. Neuron 2011, 69:599-602.
13. Der-Avakian A., Markou A. The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci 2012, 35:68-77.
14. Eisenberger N.I. The pain of social disconnection: examining the shared neural underpinnings of physical and social pain. Nat Rev Neurosci 2012, 13:421-434.
15. Moles A., Kieffer B.L., D'Amato F.R. Deficit in attachment behavior in mice lacking the mu-opioid receptor gene. Science 2004, 304:1983-1986.
16. Barr C.S., Schwandt M.L., Lindell S.G., Higley J.D., Maestripieri D., Goldman D., Suomi S.J., Heilig M. Variation at the mu-opioid receptor gene (OPRM1) influences attachment behavior in infant primates. Proc Natl Acad Sci U S A 2008, 105:5277-5281.
17. Copeland W.E., Sun H., Costello E.J., Angold A., Heilig M.A., Barr C.S. Child mu-opioid receptor gene variant influences parent-child relations. Neuropsychopharmacology 2011, 36:1165-1170.
18. Panksepp J.B., Lahvis G.P. Rodent empathy and affective neuroscience. Neurosci Biobehav Rev 2011, 35:1864-1875.
19. Trezza V., Damsteegt R., Achterberg E.J., Vanderschuren L.J. Nucleus accumbens {micro}-opioid receptors mediate social reward. J Neurosci 2011, 31:6362-6370.
20. Kennedy B.C., Panksepp J.B., Wong J.C., Krause E.J., Lahvis G.P. Age-dependent and strain-dependent influences of morphine on mouse social investigation behavior. Behav Pharmacol 2011, 22:147-159.
21. Doherty J.M., Frantz K.J. Heroin self-administration and reinstatement of heroin-seeking in adolescent vs. adult male rats. Psychopharmacology (Berl) 2011, 219:763-773.
22. Hodgson S.R., Hofford R.S., Wellman P.J., Eitan S. Different affective response to opioid withdrawal in adolescent and adult mice. Life Sci 2009, 84:52-60.
23. Lutz P.E., Reiss D., Ouagazzal A.M., Kieffer B.L. A history of chronic morphine exposure during adolescence increases despair-like behaviour and strain-dependently promotes sociability in abstinent adult mice. Behav Brain Res 2013, 10.1016/j.bbr.2012.12.049.
24. Schramm-Sapyta N.L., Walker Q.D., Caster J.M., Levin E.D., Kuhn C.M. Are adolescents more vulnerable to drug addiction than adults? Evidence from animal models. Psychopharmacology (Berl) 2009, 206:1-21.
25. Wee S., Koob G.F. The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse. Psychopharmacology (Berl) 2010, 210:121-135.
26. Resendez S.L., Kuhnmuench M., Krzywosinski T., Aragona B.J. kappa-Opioid receptors within the nucleus accumbens shell mediate pair bond maintenance. J Neurosci 2012, 32:6771-6784.
27. Bruchas M.R., Land B.B., Chavkin C. The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors. Brain Res 2010, 1314:44-55.
28. Van't Veer A., Yano J.M., Carroll F.I., Cohen B.M., Carlezon W.A. Corticotropin-releasing factor (CRF)-induced disruption of attention in rats is blocked by the kappa-opioid receptor antagonist JDTic. Neuropsychopharmacology 2012, 37:2809-2816.
29. Knoll A.T., Carlezon W.A. Dynorphin, stress, and depression. Brain Res 2010, 1314:56-73.
30. Land B.B., Bruchas M.R., Schattauer S., Giardino W.J., Aita M., Messinger D., Hnasko T.S., Palmiter R.D., Chavkin C. Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking. Proc Natl Acad Sci U S A 2009, 106:19168-19173.
31. Bruchas M.R., Schindler A.G., Shankar H., Messinger D.I., Miyatake M., Land B.B., Lemos J.C., Hagan C.E., Neumaier J.F., Quintana A., et al. Selective p38alpha MAPK deletion in serotonergic neurons produces stress resilience in models of depression and addiction. Neuron 2011, 71:498-511.
32. Schindler A.G., Messinger D.I., Smith J.S., Shankar H., Gustin R.M., Schattauer S.S., Lemos J.C., Chavkin N.W., Hagan C.E., Neumaier J.F., et al. Stress produces aversion and potentiates cocaine reward by releasing endogenous dynorphins in the ventral striatum to locally stimulate serotonin reuptake. J Neurosci 2012, 32:17582-17596.
33. Smith J.S., Schindler A.G., Martinelli E., Gustin R.M., Bruchas M.R., Chavkin C. Stress-induced activation of the dynorphin/kappa-opioid receptor system in the amygdala potentiates nicotine conditioned place preference. J Neurosci 2012, 32:1488-1495.
34. Walker B.M., Zorrilla E.P., Koob G.F. Systemic kappa-opioid receptor antagonism by nor-binaltorphimine reduces dependence-induced excessive alcohol self-administration in rats. Addict Biol 2011, 16:116-119.
35. Pradhan A.A., Befort K., Nozaki C., Gaveriaux-Ruff C., Kieffer B.L. The delta opioid receptor: an evolving target for the treatment of brain disorders. Trends Pharmacol Sci 2011, 32:581-590.
36. Shippenberg T.S., LeFevour A., Chefer V.I. Targeting endogenous mu- and delta-opioid receptor systems for the treatment of drug addiction. CNS Neurol Disord Drug Targets 2008, 7:442-453.
37. Roberts A.J., Gold L.H., Polis I., McDonald J.S., Filliol D., Kieffer B.L., Koob G.F. Increased ethanol self-administration in delta-opioid receptor knockout mice. Alcohol Clin Exp Res 2001, 25:1249-1256.
38. Margolis E.B., Fields H.L., Hjelmstad G.O., Mitchell J.M. Delta-opioid receptor expression in the ventral tegmental area protects against elevated alcohol consumption. J Neurosci 2008, 28:12672-12681.
39. Le Merrer J., Plaza-Zabala A., Del Boca C., Matifas A., Maldonado R., Kieffer B.L. Deletion of the delta opioid receptor gene impairs place conditioning but preserves morphine reinforcement. Biol Psychiatry 2011, 69:700-703.
40. Le Merrer J., Faget L., Matifas A., Kieffer B.L. Cues predicting drug or food reward restore morphine-induced place conditioning in mice lacking delta opioid receptors. Psychopharmacology (Berl) 2012, 223:99-106.
41. Faget L., Erbs E., Le Merrer J., Scherrer G., Matifas A., Benturquia N., Noble F., Decossas M., Koch M., Kessler P., et al. In vivo visualization of delta opioid receptors upon physiological activation uncovers a distinct internalization profile. J Neurosci 2012, 32:7301-7310.
42. Lutz P.E., Kieffer B.L. Opioid receptors: distinct roles in mood disorders. Trends Neurosci 2012, 10.1016/j.tins.2012.11.002.
43. Paterson N.E., Markou A. Animal models and treatments for addiction and depression co-morbidity. Neurotox Res 2007, 11:1-32.
44. Goeldner C., Lutz P.E., Darcq E., Halter T., Clesse D., Ouagazzal A.M., Kieffer B.L. Impaired emotional-like behavior and serotonergic function during protracted abstinence from chronic morphine. Biol Psychiatry 2011, 69:236-244.
45. Lutz P.E., Pradhan A.A., Goeldner C., Kieffer B.L. Sequential and opposing alterations of 5-HT(1A) receptor function during withdrawal from chronic morphine. Eur Neuropsychopharmacol 2011, 21:835-840.
46. Berrocoso E., Sanchez-Blazquez P., Garzon J., Mico J.A. Opiates as antidepressants. Curr Pharm Des 2009, 15:1612-1622.
47. Robbins T.W., Gillan C.M., Smith D.G., de Wit S., Ersche K.D. Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry. Trends Cogn Sci 2012, 16:81-91.
48. Wassum K.M., Ostlund S.B., Maidment N.T., Balleine B.W. Distinct opioid circuits determine the palatability and the desirability of rewarding events. Proc Natl Acad Sci U S A 2009, 106:12512-12517.
49. Wassum K.M., Cely I.C., Balleine B.W., Maidment N.T. {micro}-Opioid receptor activation in the basolateral amygdala mediates the learning of increases but not decreases in the incentive value of a food reward. J Neurosci 2011, 31:1591-1599.
50. Laurent V., Leung B., Maidment N., Balleine B.W. mu- and delta-opioid-related processes in the accumbens core and shell differentially mediate the influence of reward-guided and stimulus-guided decisions on choice. J Neurosci 2012, 32:1875-1883.
51. Mitchell J.M., Tavares V.C., Fields H.L., D'Esposito M., Boettiger C.A. Endogenous opioid blockade and impulsive responding in alcoholics and healthy controls. Neuropsychopharmacology 2007, 32:439-449.
52. Olmstead M.C., Ouagazzal A.M., Kieffer B.L. Mu and delta opioid receptors oppositely regulate motor impulsivity in the signaled nose poke task. PLoS ONE 2009, 4:e4410.
53. Pattij T., Schetters D., Janssen M.C., Wiskerke J., Schoffelmeer A.N. Acute effects of morphine on distinct forms of impulsive behavior in rats. Psychopharmacology (Berl) 2009, 205:489-502.
54. Befort K., Mahoney M.K., Chow C., Hayton S.J., Kieffer B.L., Olmstead M.C. Effects of delta opioid receptors activation on a response inhibition task in rats. Psychopharmacology (Berl) 2011, 214:967-976.
55. Love T.M., Stohler C.S., Zubieta J.K. Positron emission tomography measures of endogenous opioid neurotransmission and impulsiveness traits in humans. Arch Gen Psychiatry 2009, 66:1124-1134.
56. Wiskerke J., Schetters D., van Es I.E., van Mourik Y., den Hollander B.R., Schoffelmeer A.N., Pattij T. mu-Opioid receptors in the nucleus accumbens shell region mediate the effects of amphetamine on inhibitory control but not impulsive choice. J Neurosci 2011, 31:262-272.
57. Schippers M.C., Binnekade R., Schoffelmeer A.N., Pattij T., De Vries T.J. Unidirectional relationship between heroin self-administration and impulsive decision-making in rats. Psychopharmacology (Berl) 2012, 219:443-452.
58. Berger A.C., Whistler J.L. Morphine-induced mu opioid receptor trafficking enhances reward yet prevents compulsive drug use. EMBO Mol Med 2011, 3:385-397.
59. Belin D., Mar A.C., Dalley J.W., Robbins T.W., Everitt B.J. High impulsivity predicts the switch to compulsive cocaine-taking. Science 2008, 320:1352-1355.
60. Slowe S.J., Simonin F., Kieffer B., Kitchen I. Quantitative autoradiography of mu-, delta- and kappa1 opioid receptors in kappa-opioid receptor knockout mice. Brain Res 1999, 818:335-345.
61. Kitchen I., Slowe S.J., Matthes H.W., Kieffer B. Quantitative autoradiographic mapping of mu-, delta- and kappa-opioid receptors in knockout mice lacking the mu-opioid receptor gene. Brain Res 1997, 778:73-88.
62. Goody R.J., Oakley S.M., Filliol D., Kieffer B.L., Kitchen I. Quantitative autoradiographic mapping of opioid receptors in the brain of delta-opioid receptor gene knockout mice. Brain Res 2002, 945:9-19.
63. Schumann G., Loth E., Banaschewski T., Barbot A., Barker G., Buchel C., Conrod P.J., Dalley J.W., Flor H., Gallinat J., et al. The IMAGEN study: reinforcement-related behaviour in normal brain function and psychopathology. Mol Psychiatry 2010, 15:1128-1139.